BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7823898)

  • 1. [Morphological atypism and clinicopathological factors in colorectal adenoma and cancer using nuclear DNA content, p53 and PCNA].
    Yamamoto H; Yamada N; Asano G; Shoji T
    Nihon Geka Gakkai Zasshi; 1994 Oct; 95(10):763-74. PubMed ID: 7823898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
    Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
    Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
    Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
    J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of cancer clones in human colorectal adenoma as revealed by increased DNA instability and other bio-markers.
    Jin Y; Sun A; Noriki S; Imamura Y; Fukuda M
    Eur J Histochem; 2007; 51(1):1-10. PubMed ID: 17548263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms.
    Tagawa Y; Yasutake T; Sawai T; Nanashima A; Jibiki M; Morinaga M; Akama F; Nakagoe T; Ayabe H
    Clin Cancer Res; 1997 Sep; 3(9):1587-92. PubMed ID: 9815847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of different biomarkers (DNA content, PCNA, karyotype) in colorectal adenomas.
    Lavezzi AM; Ottaviani G; De Ruberto F; Fichera G; Matturri L
    Anticancer Res; 2002; 22(4):2077-81. PubMed ID: 12174886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results of p53 immunostaining in colorectal adenomas, early cancers, advanced cancers and their hepatic metastasis].
    Saigusa N; Maruyama K; Sugimura H; Endoh Y; Baba S
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():159-63. PubMed ID: 8678561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA.
    Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Miwa A
    Hepatogastroenterology; 1999; 46(27):1959-62. PubMed ID: 10430377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow cytometric analysis of DNA ploidy in colorectal adenoma].
    Chiba S; Fujimaki E; Nakano O; Orii S; Sato S; Sasaki K
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):767-70. PubMed ID: 8489283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytometric measurement of p53 protein and DNA content in colorectal carcinomas with liver metastasis].
    Kimura O; Hisamitsu K; Sugamura K; Nakamura S; Kurayoshi K; Makino M; Kaibara N
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():134-9. PubMed ID: 7611776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
    Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
    Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
    Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
    Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of cancer cell growth and apoptosis in morphogenesis of colorectal cancer].
    Seki H
    Hokkaido Igaku Zasshi; 2000 Sep; 75(5):325-34. PubMed ID: 11070793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
    Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
    Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Image analysis on isolated colorectal tumor cells].
    Kubo H; Murata S; Urata Y; Itoi H; Oka T; Ashihara T
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):748-51. PubMed ID: 8489278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear DNA content, S-phase fraction analysis and expression of proliferating cell nuclear antigen (PCNA) of normal and hyperplastic/neoplastic parathyroid glands.
    Suzuki S; Tsuchiya A; Hara K; Abe R
    Fukushima J Med Sci; 1997 Jun; 43(1):41-50. PubMed ID: 9431783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
    Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
    Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of nuclear accumulation of p53 protein in gastric cancer.
    Uchino S; Noguchi M; Hirota T; Itabashi M; Saito T; Kobayashi M; Hirohashi S
    Jpn J Clin Oncol; 1992 Aug; 22(4):225-31. PubMed ID: 1279244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.